Your browser doesn't support javascript.
loading
Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib.
White, Maya N; Piper-Vallillo, Andrew J; Gardner, Rebecca M; Cunanan, Kristen; Neal, Joel W; Das, Millie; Padda, Sukhmani K; Ramchandran, Kavitha; Chen, Thomas T; Sequist, Lecia V; Piotrowska, Zofia; Wakelee, Heather A.
Affiliation
  • White MN; Department of Medicine, Division of Oncology, Stanford University, Stanford CA.
  • Piper-Vallillo AJ; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA.
  • Gardner RM; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA.
  • Cunanan K; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA.
  • Neal JW; Department of Medicine, Division of Oncology, Stanford University, Stanford CA.
  • Das M; Department of Medicine, Division of Oncology, Stanford University, Stanford CA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA.
  • Padda SK; Department of Medicine, Division of Oncology, Stanford University, Stanford CA.
  • Ramchandran K; Department of Medicine, Division of Oncology, Stanford University, Stanford CA.
  • Chen TT; Stanford Cancer Center South Bay, San Jose, CA.
  • Sequist LV; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA.
  • Piotrowska Z; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA.
  • Wakelee HA; Department of Medicine, Division of Oncology, Stanford University, Stanford CA. Electronic address: hwakelee@stanford.edu.
Clin Lung Cancer ; 23(3): e210-e221, 2022 05.
Article de En | MEDLINE | ID: mdl-34887193
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Lung Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Lung Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique